Conserved residues in Lassa fever virus Z protein modulate viral infectivity at the level of the ribonucleoprotein

J Virol. 2011 Apr;85(7):3172-8. doi: 10.1128/JVI.02081-10. Epub 2011 Jan 12.

Abstract

Arenaviruses are negative-strand RNA viruses that cause human diseases such as lymphocytic choriomeningitis, Bolivian hemorrhagic fever, and Lassa hemorrhagic fever. No licensed vaccines exist, and current treatment is limited to ribavirin. The prototypic arenavirus, lymphocytic choriomeningitis virus (LCMV), is a model for dissecting virus-host interactions in persistent and acute disease. The RING finger protein Z has been identified as the driving force of arenaviral budding and acts as the viral matrix protein. While residues in Z required for viral budding have been described, residues that govern the Z matrix function(s) have yet to be fully elucidated. Because this matrix function is integral to viral assembly, we reasoned that this would be reflected in sequence conservation. Using sequence alignment, we identified several conserved residues in Z outside the RING and late domains. Nine residues were each mutated to alanine in Lassa fever virus Z. All of the mutations affected the expression of an LCMV minigenome and the infectivity of virus-like particles, but to greatly varying degrees. Interestingly, no mutations appeared to affect Z-mediated budding or association with viral GP. Our findings provide direct experimental evidence supporting a role for Z in the modulation of the activity of the viral ribonucleoprotein (RNP) complex and its packaging into mature infectious viral particles.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acid Sequence
  • Amino Acid Substitution / genetics
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism*
  • Cell Line
  • Conserved Sequence
  • Humans
  • Lassa virus / physiology*
  • Models, Biological
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Mutant Proteins / genetics
  • Mutant Proteins / metabolism
  • RNA-Binding Proteins
  • Ribonucleoproteins / genetics
  • Ribonucleoproteins / metabolism*
  • Sequence Alignment
  • Viral Matrix Proteins / genetics
  • Viral Matrix Proteins / metabolism*
  • Virulence Factors / genetics
  • Virulence Factors / metabolism*
  • Virus Assembly*

Substances

  • Carrier Proteins
  • Mutant Proteins
  • RNA-Binding Proteins
  • Ribonucleoproteins
  • Viral Matrix Proteins
  • Virulence Factors
  • protein Z, Lassa virus